Nectin Therapeutics Ltd. raised $10 million in a private equity funding round led by Guangzhou-Israel Biotechnology Fund (GIBF) to advance novel pipeline of First-in-Class Immunotherapies and Antibody Drug Conjugates.
Amount Raised
$10 Million
Round Type
Private Equity
JerusalemBiotechnologyHealth CareTherapeuticsInvestors
Description
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics Ltd. The proceeds from the financing will support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates.
Quick answer
Nectin Therapeutics raised $10 Million in a Private Equity round, dated May 6, 2024. Investors: Guangzhou Israel Biotechnology Fund (Gibf). Nectin Therapeutics is based in Jerusalem, Jerusalem District, Israel.
- How much did Nectin Therapeutics raise?
- Nectin Therapeutics raised $10 Million in a Private Equity round on May 6, 2024.
- Who invested in Nectin Therapeutics?
- Guangzhou Israel Biotechnology Fund (Gibf) is named as investors in this round.
- What does Nectin Therapeutics do?
- Nectin Therapeutics is a biotech company focused on unlocking the power of the immune system.
- Where is Nectin Therapeutics based and how big is it?
- Nectin Therapeutics is based in Jerusalem, Jerusalem District, Israel.
- Who are the decision-makers at Nectin Therapeutics?
- Fundz holds 1 contact at Nectin Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Nectin Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- āshibio raised $40M (Series A) on June 20, 2024.
- iOnctura BV raised $86M (Series B) on June 20, 2024.
- Autobahn Therapeutics raised $101M on June 20, 2024.
- Mustang Bio raised $2.5M on June 19, 2024.
- Canton Strategic Holdings, Inc. raised $2.1M on June 18, 2024.
- InduPro raised $85M (Series A) on June 13, 2024.
Who to call at Nectin Therapeutics, and when
A new round usually means Nectin Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nectin Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nectin Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nectin Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nectin Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nectin Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.